Arvind Tewari joined atai Life Sciences as Vice-President, Digital Strategy & Operations in 2021. Atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Amongst the most important approaches that Atai is pursuing is the combination of digital and psychedelic therapies. Headquartered in Berlin, with offices in New York and London, their vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life.
Previously, Arvind was Chief Operating Officer and acting Chief Executive Officer at Oxford VR where he was responsible for strategy, product development and clinical trial, and commercial implementation. Prior to that, he was an Investment Manager at Epiris Private Equity where he was responsible for the due diligence, execution, portfolio management, and digital transformation of buy-out investments into private companies of £100m – £500m in valuation.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.